TransMedics to Provide Update on Ongoing Clinical Programs at the International Society of Heart and Lung Transplantation 2026 Annual Meeting
TransMedics unveiled the Controlled Hypothermic Organ Preservation System (CHOPS) at the ISHLT 2026 Annual Meeting to support its clinical programs and expand its product portfolio. CHOPS is an active cooling device designed to facilitate control arm enrollment in the OCS ENHANCE Heart Part B and OCS DENOVO Lung trials by providing a stable alternative to static cold storage.
Key figures
- Drug Name
- Controlled Hypothermic Organ Preservation System (CHOPS), OCS ENHANCE Heart, OCS DENOVO Lung
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.